Characterization of the envelope glycoprotein of a novel filovirus, Lloviu virus

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 99-109

  Maruyama, Junki ^a   Miyamoto, Hiroko ^a   Kajihara, Masahiro ^a   Ogawa, Hirohito ^a,b   Maeda, Ken ^c   Sakoda, Yoshihiro ^d   Yoshida, Reiko ^a   Takada, Ayato ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; LECTIN; MATRIX PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENDOSOME; FILOVIRUS; FILOVIRUS INFECTION; HUMAN; HUMAN CELL; LLOVIVIRUS; NEW SPECIES; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES DIFFERENCE; VESICULAR STOMATITIS VIRUS; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS PARTICLE; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CROSS REACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FILOVIRIDAE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS; VIRAL TROPISM;

EID: 84890869251     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02265-13     Document Type: Article

References (58)

1. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849-862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8.
2. Fisher-Hoch SP, McCormick JB. 1999. Experimental filovirus infections. Curr. Top. Microbiol. Immunol. 235:117-143. http://dx.doi.org/10.1007 /978-3-642-59949-1_8.
3. Geisbert TW, Hensley LE. 2004. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert. Rev. Mol. Med. 6:1-24. http://dx.doi.org/10.1017/S1462399404008300.
4. Negredo A, Palacios G, Vázquez-Morón S, González F, Dopazo H, Molero F, Juste J, Quetglas J, Savji N, de la Cruz Martínez M, Herrera JE, Pizarro M, Hutchison SK, Echevarría JE, Lipkin WI, Tenorio A. 2011. Discovery of an ebolavirus-like filovirus in Europe. PLoS Pathog. 7:e1002304. http://dx.doi.org/10.1371/journal.ppat.1002304.
5. Elliott LH, Kiley MP, McCormick JB. 1985. Descriptive analysis of Ebola virus proteins. Virology 147:169 -176. http://dx.doi.org/10.1016 /0042-6822(85)90236-3.
6. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 94:14764-14769. http://dx.doi.org /10.1073/pnas.94.26.14764.
7. Wool-Lewis RJ, Bates P. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.
8. Manicassamy B, Wang J, Rumschlag E, Tymen S, Volchkova V, Volchkov V, Rong L. 2007. Characterization of Marburg virus glycoprotein in viral entry. Virology 358:79-88. http://dx.doi.org/10.1016/j.virol.2006.06 .041.
9. Geyer H, Will C, Feldmann H, Klenk HD, Geyer R. 1992. Carbohydrate structure of Marburg virus glycoprotein. Glycobiology 2:299-312. http: //dx.doi.org/10.1093/glycob/2.4.299.
10. Feldmann H, Nichol ST, Klenk HD, Peters CJ, Sanchez A. 1994. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199:469-473. http://dx.doi .org/10.1006/viro.1994.1147.
11. Alvarez CP, Lasala F, Carrillo J, Muñiz O, Corbí AL, Delgado R. 2002. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76:6841-6844. http://dx.doi.org/10.1128/JVI .76.13.6841-6844.2002.
12. Baribaud F, Pöhlmann S, Leslie G, Mortari F, Doms RW. 2002. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte- derived dendritic cells. J. Virol. 76:9135-9142. http://dx.doi.org/10 .1128/JVI.76.18.9135-9142.2002.
13. Lin G, Simmons G, Pöhlmann S, Baribaud F, Ni H, Leslie GJ, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW. 2003. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77:1337-1346. http://dx.doi.org/10.1128/JVI.77.2 .1337-1346.2003.
14. Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. 2007. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J. Infect. Dis. 196(Suppl 2):S347-S356. http://dx.doi.org/10 .1086/520581.
15. Nakayama E, Tomabechi D, Matsuno K, Kishida N, Yoshida R, Feldmann H, Takada A. 2011. Antibody-dependent enhancement of Marburg virus infection. J. Infect. Dis. 204(Suppl 3):S978-S985. http://dx.doi .org/10.1093/infdis/jir334.
16. Feldmann H, Mühlberger E, Randolf A, Will C, Kiley MP, Sanchez A, Klenk HD. 1992. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 24:1-19. http: //dx.doi.org/10.1016/0168-1702(92)90027-7.
17. Sakoda Y, Fukusho A. 1998. Establishment and characterization of a porcine kidney cell line, FS-L3, which forms unique multicellular domes in serum-free culture. In Vitro Cell. Dev. Biol. Anim. 34:53-57. http://dx .doi.org/10.1007/s11626-998-0053-6.
18. Maeda K, Hondo E, Terakawa J, Kiso Y, Nakaichi N, Endoh D, Sakai K, Morikawa S, Mizutani T. 2008. Isolation of novel adenovirus from fruit bat (Pteropus dasymallus yayeyamae). Emerg. Infect. Dis. 14:347-349. http://dx.doi.org/10.3201/eid1402.070932.
19. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, Kobasa D, Feldmann H, Irimura T, Kawaoka Y. 2004. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 78:2943-2947. http://dx.doi.org/10.1128 /JVI.78.6.2943-2947.2004.
20. Matsuno K, Kishida N, Usami K, Igarashi M, Yoshida R, Nakayama E, Shimojima M, Feldmann H, Irimura T, Kawaoka Y, Takada A. 2010. Different potential of C-type lectin-mediated entry between Marburg virus strains. J. Virol. 84:5140-5147. http://dx.doi.org/10.1128/JVI.02021 -09.
21. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. U. S. A. 93:3602-3607. http://dx.doi.org/10.1073/pnas.93.8.3602.
22. Volchkov VE, Becker S, Volchkova VA, Ternovoj VA, Kotov AN, Netesov SV, Klenk HD. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214:421-430. http://dx.doi.org/10.1006/viro.1995.0052.
23. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193- 199. http://dx.doi.org/10.1016/0378-1119(91)90434-D.
24. Changula K, Yoshida R, Noyori O, Marzi A, Miyamoto H, Ishijima M, Yokoyama A, Kajihara M, Feldmann H, Mweene AS, Takada A. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein. Virus Res. 176:83-90. http://dx.doi.org/10.1016/j .virusres.2013.05.004.
25. Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, Matsuno K, Marzi A, Feldmann H, Ito K, Saijo M, Takada A. 2010. Enzyme-linked immunosorbent assay for detection of filovirus speciesspecific antibodies. Clin. Vaccine Immunol. 17:1723-1728. http://dx.doi .org/10.1128/CVI.00170-10.
26. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. 2002. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J. Virol. 76:4855-4865. http://dx.doi.org/10.1128/JVI.76.10 .4855-4865.2002.
27. Noda T, Ebihara H, Muramoto Y, Fujii K, Takada A, Sagara H, Kim JH, Kida H, Feldmann H, Kawaoka Y. 2006. Assembly and budding of ebolavirus. PLoS Pathog. 2:e99. http://dx.doi.org/10.1371/journal.ppat .0020099.
28. Johnson RF, Bell P, Harty RN. 2006. Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virol. J. 3:31. http://dx.doi.org /10.1186/1743-422X-3-31.
29. Geisbert TW, Jahrling PB. 1995. Differentiation of filoviruses by electron microscopy. Virus Res. 39:129-150. http://dx.doi.org/10.1016/0168 -1702(95)00080-1.
30. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. http://dx.doi.org/10.1126/science.1110656.
31. Takada A, Watanabe S, Okazaki K, Kida H, Kawaoka Y. 2001. Infectivity- enhancing antibodies to Ebola virus glycoprotein. J. Virol. 75:2324- 2330. http://dx.doi.org/10.1128/JVI.75.5.2324-2330.2001.
32. Takada A, Kawaoka Y. 2003. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol. 13:387-398. http://dx.doi.org/10.1002/rmv.405.
33. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, Formenty PB, Albarino CG, Miller DM, Reed ZD, Kayiwa JT, Mills JN, Cannon DL, Greer PW, Byaruhanga E, Farnon EC, Atimnedi P, Okware S, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Ksiazek TG, Nichol ST, Rollin PE. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 5:e1000536. http://dx.doi.org/10.1371 /journal.ppat.1000536.
34. Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, Kemp A, Erickson BR, Comer JA, Campbell S, Cannon DL, Khristova ML, Atimnedi P, Paddock CD, Crockett RJ, Flietstra TD, Warfield KL, Unfer R, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Rollin PE, Ksiazek TG, Nichol ST, Towner JS. 2012. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 8:e1002877. http://dx.doi.org/10.1371/journal.ppat.1002877.
35. Towner JS, Pourrut X, Albariño CG, Nkogue CN, Bird BH, Grard G, Ksiazek TG, Gonzalez JP, Nichol ST, Leroy EM. 2007. Marburg virus infection detected in a common African bat. PLoS One 2:e764. http://dx.doi.org/10.1371/journal.pone.0000764.
36. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez JP, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575-576. http://dx.doi.org/10.1038 /438575a.
37. Pourrut X, Souris M, Towner JS, Rollin PE, Nichol ST, Gonzalez JP, Leroy E. 2009. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect. Dis. 9:159. http://dx.doi.org/10.1186/1471-2334-9-159.
38. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. 1998. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. U. S. A. 95:5762-5767. http://dx.doi.org/10.1073/pnas.95.10.5762.
39. Volchkov VE, Volchkova VA, Ströher U, Becker S, Dolnik O, Cieplik M, Garten W, Klenk HD, Feldmann H. 2000. Proteolytic processing of Marburg virus glycoprotein. Virology 268:1-6. http://dx.doi.org/10.1006 /viro.1999.0110.
40. Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Cote M, Sullivan N, Fabozzi G, Hensley L. 2012. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J. Virol. 86:3284-3292. http://dx.doi.org/10.1128/JVI.06346-11.
41. Marzi A, Reinheckel T, Feldmann H. 2012. Cathepsin B & L are not required for Ebola virus replication. PLoS Negl. Trop. Dis. 6:e1923. http: //dx.doi.org/10.1371/journal.pntd.0001923.
42. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pöhlmann S. 2003. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305:115-123. http://dx.doi.org/10.1006/viro.2002.1730.
43. Dominguez-Soto A, Aragoneses-Fenoll L, Martin-Gayo E, Martinez-Prats L, Colmenares M, Naranjo-Gomez M, Borras FE, Munoz P, Zubiaur M, Toribio ML, Delgado R, Corbi AL. 2007. The DC-SIGNrelated lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood 109:5337-5345. http://dx.doi.org/10.1182 /blood-2006-09-048058.
44. Powlesland AS, Fisch T, Taylor ME, Smith DF, Tissot B, Dell A, Pöhlmann S, Drickamer K. 2008. A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J. Biol. Chem. 283:593-602.
45. Matsuno K, Nakayama E, Noyori O, Marzi A, Ebihara H, Irimura T, Feldmann H, Takada A. 2010. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem. Biophys. Res. Commun. 403:144-148. http://dx.doi.org/10.1016/j.bbrc.2010.10.136.
46. Marzi A, Möller P, Hanna SL, Harrer T, Eisemann J, Steinkasserer A, Becker S, Baribaud F, Pöhlmann S. 2007. Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DCSIGNR. J. Infect. Dis. 196(Suppl 2):S237-S246. http://dx.doi.org/10.1086 /520607.
47. Feinberg H, Mitchell DA, Drickamer K, Weis WI. 2001. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294:2163-2166. http://dx.doi.org/10.1126/science.1066371.
48. Higashi N, Fujioka K, Denda-Nagai K, Hashimoto S, Nagai S, Sato T, Fujita Y, Morikawa A, Tsuiji M, Miyata-Takeuchi M, Sano Y, Suzuki N, Yamamoto K, Matsushima K, Irimura T. 2002. The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J. Biol. Chem. 277:20686-20693. http://dx.doi.org/10.1074/jbc.M202104200.
49. Suzuki N, Yamamoto K, Toyoshima S, Osawa T, Irimura T. 1996. Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen. J. Immunol. 156:128-135.
50. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, Nichol ST, Rollin PE, Towner JS, Shieh WJ, Batten B, Sealy TK, Carrillo C, Moran KE, Bracht AJ, Mayr GA, Sirios-Cruz M, Catbagan DP, Lautner EA, Ksiazek TG, White WR, McIntosh MT. 2009. Discovery of swine as a host for the Reston ebolavirus. Science 325:204-206. http://dx.doi.org/10.1126/science.1172705.
51. Marsh GA, Haining J, Robinson R, Foord A, Yamada M, Barr JA, Payne J, White J, Yu M, Bingham J, Rollin PE, Nichol ST, Wang LF, Middleton D. 2011. Ebola Reston virus infection of pigs: clinical significance and transmission potential. J. Infect. Dis. 204(Suppl 3):S804-S809. http://dx.doi.org/10.1093/infdis/jir300.
52. Pan Y, Zhang W, Cui L, Hua X, Wang M, Zeng Q. 21 September 2012. Reston virus in domestic pigs in China. Arch. Virol. http://dx.doi.org/10.1007/s00705-012-1477-6.
53. Nfon CK, Leung A, Smith G, Embury-Hyatt C, Kobinger G, Weingartl HM. 2013. Immunopathogenesis of severe acute respiratory disease in Zaire ebolavirus-infected pigs. PLoS One 8:e61904. http://dx.doi.org/10.1371/journal.pone.0061904.
54. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Jr, Chiorini J, Maury W. 2011. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. U. S. A. 108:8426-8431. http://dx.doi.org/10.1073/pnas.1019030108.
55. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. 2006. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J. Virol. 80:10109-10116. http://dx.doi.org/10.1128/JVI.01157-06.
56. Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. 2011. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344-348. http://dx.doi.org/10.1038/nature10380.
57. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343. http://dx.doi.org/10.1038/nature10348.
58. Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, Kemp A, Burt FJ, Grobbelaar AA, Croft J, Bausch DG, Zeller H, Leirs H, Braack LE, Libande ML, Zaki S, Nichol ST, Ksiazek TG, Paweska JT. 2007. Studies of reservoir hosts for Marburg virus. Emerg. Infect. Dis. 13:1847-1851. http://dx.doi.org/10.3201/eid1312.071115.